Rapid Micro Q1 revenue $7.2M (+28% YoY), gross margin turns positive 6%, net loss narrows to $11.3M

RAPID MICRO BIOSYSTEMS, INC.

2025-Q1 EPS reported -$0.26 revenue$7,205,000

Product revenue $4.1M (+10%), service revenue $3.1M (+64%) driven by record validation activity; 3 new Growth Direct placements.
Gross margin improved to 6% from -27% in Q1 2024; total operating expenses down 5% to $12.1M.
Net loss per share $0.26 vs $0.31; cash & equivalents $42M with no debt outstanding.
Global distribution agreement with MilliporeSigma (Merck KGaA) announced; joint training and planning underway.
FY2025 guidance reaffirmed: total revenue at least $32M with 21-25 system placements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.